$NKTR News AstraZeneca's NDA for Naloxegol accepted 3:35

New Post Public Reply Private Reply Replies (0) Message Board

Dec 13, 2013 at 12:44 PM

$NKTR News

AstraZeneca's NDA for Naloxegol accepted 3:35 a.m. Nov. 19, 2013 - MarketWatch.com
Nektar Therapeutics shares soar on earnings, new drug prospects 12:31 p.m. Nov. 8, 2013 - Russ Britt
Rough market day for Nektar, while Pharmacyclics and Regeneron soar 5:21 p.m. Sept. 26, 2013 - Russ Britt
Nike shares swoosh higher after earnings 4:53 p.m. Sept. 26, 2013 - Wallace Witkowski
Nektar shares drop 25% after study misses endpoint 3:45 p.m. Sept. 26, 2013 - Wallace Witkowski
FDA grants fast-track status for Nektar drug 10:43 a.m. Nov. 7, 2012 - MarketWatch.com
S&P 500 clears trendline resistance 10:01 a.m. July 30, 2012 - Michael Ashbaugh
Charting the latest tape bomb 10:02 a.m. July 23, 2012 - Michael Ashbaugh
Wednesday’s biggest gaining & declining stocks 5:04 p.m. Feb. 29, 2012 - Kate Gibson
Nektar sells royalties for two drugs 11:31 a.m. Feb. 29, 2012 - MarketWatch.com
S&P 500 vacillates at the March peak 9:47 a.m. April 4, 2011 - Michael Ashbaugh
Wednesday’s biggest gaining and declining stocks 4:24 p.m. Jan. 19, 2011 - Kate Gibson
Monday’s biggest gaining and declining stocks 4:24 p.m. Dec. 13, 2010 - Kate Gibson
Drug indexes hug the flat line 10:57 a.m. Dec. 13, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 4:40 p.m. March 3, 2010 - MarketWatch
Nasdaq hesitates at the 50-day moving average 9:46 a.m. Feb. 18, 2010 - Michael Ashbaugh
S&P 500 settling into the 2004 trading range? 11:38 a.m. Feb. 1, 2010 - Michael Ashbaugh
S&P pulls in from the 1,100 mark 9:15 a.m. Oct. 16, 2009 - Michael Ashbaugh
U.S. benchmarks survive initial test of the 50-day 9:19 a.m. Oct. 5, 2009 - Michael Ashbaugh
Miners, banks weigh on U.K. market 11:07 a.m. Sept. 21, 2009 - Simon Kennedy

Timing And Good Science: Is Now The Time To Get On Board With Nektar? 11:18 a.m. Dec. 3, 2013 - Seeking Alpha
UPDATE: Piper Jaffray Initiates Coverage on Nektar Therapeutics on Expected Attractive Returns 9:53 a.m. Nov. 27, 2013 - benzinga.com
Healthcare coverage initiations roundup 8:55 a.m. Nov. 27, 2013 - Seeking Alpha
FDA to Review Nektar/AZN Drug - Analyst Blog 6:35 p.m. Nov. 20, 2013 - Zacks.com
US Stock Futures Edge Lower Ahead Of Earnings 6:53 a.m. Nov. 19, 2013 - benzinga.com
Nektar, Astra Zeneca Announce NDA for Naloxegol Accepted by FDA 6:07 a.m. Nov. 19, 2013 - benzinga.com
Baxter Advances on Pivotal Study - Analyst Blog 3:10 p.m. Nov. 15, 2013 - Zacks.com
Narrower-than-Expected Q3 Loss at Nektar - Analyst Blog 4:30 p.m. Nov. 8, 2013 - Zacks.com
Nektar Therapeutics' CEO Discusses Q3 2013 Results - Earnings Call Transcript 9:54 p.m. Nov. 7, 2013 - Seeking Alpha
10-Q: NEKTAR THERAPEUTICS 5:10 p.m. Nov. 7, 2013 - Edgar Online - (EDG = 10Q, 10K)
Short Interest In Nektar Therapeutics Falls 12.5% 2:49 p.m. Oct. 11, 2013 - TheStreet.com
Should Investors Have A Sweet Tooth For Nektar? 1:34 p.m. Oct. 11, 2013 - Seeking Alpha
Pipeline Update at Nektar - Analyst Blog 3:45 p.m. Oct. 9, 2013 - Zacks.com
Oversold Conditions For Nektar Therapeutics (NKTR) 12:06 p.m. Oct. 9, 2013 - TheStreet.com
Nektar Therapeutics' CEO Hosts Investor and Analyst R&D Day Conference (Transcript) 6:35 p.m. Oct. 8, 2013 - Seeking Alpha
Nektar Reports on Advancements with Clinical Pipeline and Introduces New Preclinical Candidates at Investor and Analyst R&D Day 10:15 a.m. Oct. 8, 2013 - benzinga.com
Pipeline Progresses at AstraZeneca - Analyst Blog 5:00 p.m. Sept. 30, 2013 - Zacks.com
Trade-Ideas: Nektar Therapeutics (NKTR) Is Today's "Dead Cat Bounce" Stock 10:38 a.m. Sept. 30, 2013 - TheStreet.com
Nektar Reports AstraZeneca Receives EMA Acceptance of Marketing Authorization Application for Naloxegol 4:41 a.m. Sept. 30, 2013 - benzinga.com
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 8:07 p.m. Sept. 27, 2013 - TheStreet.com

New Research Arrangements, Investor Conference Schedules, Reimbursement Agreements, and NDA Acceptances - Research Report on Quintiles, Insys, HeartWare, Given Imaging, and Nektar 8:00 a.m. Nov. 28, 2013 - PR Newswire
Financing, Special Reports, and Clinical Trial Updates - Research Report on PDL, DexCom, Quintiles, KYTHERA, and Nektar 8:00 a.m. Nov. 20, 2013 - PR Newswire
Morning Research: Inovio Pharma Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 9:03 a.m. Nov. 19, 2013 - PR Newswire
New Drug Application For Naloxegol Accepted By United States Food And Drug Administration 7:00 a.m. Nov. 19, 2013 - PR Newswire
Baxter Completes Enrollment In Phase III Clinical Trial Of BAX 855, Extended Half-life Recombinant FVIII For Hemophilia A 9:34 a.m. Nov. 13, 2013 - PR Newswire
Baxter Completes Enrollment in Phase III Clinical Trial of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A 9:00 a.m. Nov. 13, 2013 - BusinessWire
Updates on Clinical Studies and Milestone Revenues - Research Report on Cyberonics, West, Nektar, OraSure, and Akorn 8:00 a.m. Nov. 12, 2013 - PR Newswire
Critical Alerts For Salix Pharmaceuticals, Endo Pharmaceuticals, Nektar Therapeutics, Riverbed Technology, and Ubiquiti Networks Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire
Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013 4:15 p.m. Nov. 7, 2013 - PR Newswire
Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets 5:00 p.m. Oct. 30, 2013 - PR Newswire
Today's Research: Inovio Pharmaceuticals Inc., Sequenom Inc., Nektar Therapeutics, and Discovery Laboratories Inc. 9:00 a.m. Oct. 28, 2013 - PR Newswire
Nektar and Roswell Park Cancer Institute Announce Initiation of Investigator-Sponsored Trial Evaluating Etirinotecan Pegol (NKTR-102) as a Second-Line Treatment in Patients with Relapsed or Refractory Small Cell Lung Cancer (SCLC) 8:00 a.m. Oct. 24, 2013 - PR Newswire
Dividend Announcements, Earnings Release Scheduled, and Data Presentations from Clinical Studies - Research Report on Questcor, Regeneron, NPS, Incyte, and Nektar 8:00 a.m. Oct. 16, 2013 - PR Newswire
AstraZeneca Announces New Safety Data For Naloxegol In Patients with Opioid-Induced Constipation 10:26 a.m. Oct. 14, 2013 - BusinessWire
Nektar Reports on Advancements with Clinical Pipeline and Introduces New Preclinical Candidates at Investor and Analyst R&D Day 11:15 a.m. Oct. 8, 2013 - PR Newswire
Regulatory Approvals, Public Offerings and Clinical Trial Results - Research Report on Theravance, Synageva, Nektar, Clovis Oncology, and ImmunoGen 8:00 a.m. Oct. 7, 2013 - PR Newswire
Nektar to Host Investor and Analyst R&D Day in New York City 8:30 p.m. Oct. 2, 2013 - PR Newswire
Presentation on Research Findings, Recognitions, Clinical Trial Results, and Orphan Drug Designations - Research Report on Celgene, Biogen Idec, Amgen, Nektar, and Zalicus 8:00 a.m. Oct. 2, 2013 - PR Newswire
Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol 5:30 a.m. Sept. 30, 2013 - PR Newswire
Nektar Announces Preliminary Topline Results from Phase 2 Efficacy Study for NKTR-181 in Chronic Pain Patients with Osteoarthritis of the Knee 4:10 p.m. Sept. 26, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NACD Honors Top Board Leaders with 2026 Awards

Celebrating Boardroom Mavericks at NACD Gala September 2026 has brought some sparkling recognition to the elites guiding today's corporate governance landscapes. The National Association of Corporate Directors (NACD) has announced their Directorship 100 honorees, tipping their hats to stellar individuals firing on all cylinders in the boardroom. Who's Getting the Nod?...

Annex Brands Grows with Bastrop's PostalAnnex Opening

New PostalAnnex Location Opens in Bastrop, TX Here's a fresh chapter in the books for Annex Brands, Inc. They've just cut the ribbon on a brand spanking new PostalAnnex in Bastrop, Texas, handing the reins over to eager fresh faces, Chetan Modi and Karan Desai. And you know what? This ain't just any regular location. It's a one-stop-shop for anything you could need, from...

Lavior and CR Fitness Team for Wellness Reach

Botanical Care Meets Gym Life in the Southeast Lavior, the botanical whiz kids of wound and skin care out of Miami, are shaking hands with CR Fitness, Crunch's big-time franchise operator carrying the flag across the Southeast. They’ve ironed out a deal that’ll park Lavior’s products in more than 60 gyms covering Florida, Georgia, North Carolina, and Texas. It’s a...

Molex's VersaBeam Mini Pushes AI Data Center Limits

Game-Changer for AI Data Centers? Across the tech landscape, space is a premium, and Molex's new VersaBeam Mini arrives like a hail Mary in the fourth quarter. In AI data centers, squeezing down every single component counts—especially when optical density's in play. What we're seeing here is a potential paradigm shift. A 3x density improvement from a tiny 3.5 x 9 mm...

Lawsuit Targets Electrical Consultants' Labor Practices

Trouble Brews at Electrical Consultants, Inc. Right on the heels of a long workday, some employees of Electrical Consultants, Inc. seem to be getting a double whammy. The company is tangled up in a class action lawsuit lodged by the well-known Blumenthal Nordrehaug Bhowmik De Blouw LLP. This ain't your everyday grievance, folks; we're talking meal and rest period...

HNTB Expands in Capital Region: A Strategic Move

Breaking New Ground in Arlington and Baltimore Deepening their stake in the Capital Region's future, HNTB has thrown open new office doors in Arlington, Virginia, and Baltimore, Maryland. We're not just talking fancy buildings, folks—this is about securing a piece of the infrastructure pie that's only going to get bigger and tastier. Infrastructure's the backbone of...

Nature-Based Solutions: The Economic And Community Impact

Harnessing Nature to Boost Economies You ever stop to think about how nature itself might just be the best investment? Well, the Walton Family Foundation surely does, betting big on nature-based solutions. Their latest initiative, 'Human Nature,' is shedding light on how these solutions aren't just saving ecosystems — they're fortifying economies and enriching...

Tenera Care's Tech Triumph: Halving Falls with Simplicity

Every once in a while, a piece of tech comes along that makes you sit up and say, ‘Now that’s a game-changer!’ And with the recent rave reviews, Tenera Care seems to hit just that sweet spot for folks in the senior living game. By handing Dublin Glenn Memory Care the gold in the KISS category at the 2026 McKnight's Technology Awards, it’s clear the industry is...

Castillo Engineering Gears Up with New VP Appointments

New Leadership to Drive Expansion In a boost to its commitment to scaling up, Castillo Engineering, based in Maitland, Florida, has roped in two veterans from the renewables sector as vice presidents. Aaron Carrillo and Devin Radovich, who share a history of successful collaboration at Renewable Energy Systems Americas (RES), are set to guide Castillo's growth in the...

Navigating AI's New Era: Dresner's 2026 Findings

Big Insights in the AI World of 2026 Well folks, if there's one thing making waves in the boardrooms this year, it's AI. Dresner Advisory Services just threw down a gauntlet for companies with their fresh batch of reports focused on the dizzying world of AI. They ripped right into it, exploring how firms can bag a heap of benefits and deal with the hurdles that come with...